SIRT3 is correlated with the malignancy of non-small cell lung cancer
Yanlu Xiong(Chinese PLA General Hospital), Yong Han(Xi'an Jiaotong University)
Cited by 40
Related Papers
Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy
|Cancer Medicine|2018|703
Sirt3 modulate renal ischemia‐reperfusion injury through enhancing mitochondrial fusion and activating the ERK‐OPA1 signaling pathway
|Journal of Cellular Physiology|2019|115
Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model
|Frontiers in Oncology|2021|106
TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway
|Translational Oncology|2024|17